{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:34:11Z","timestamp":1773956051011,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Suzhou New District","award":["2019F002"],"award-info":[{"award-number":["2019F002"]}]},{"name":"Suzhou New District","award":["2017Z008"],"award-info":[{"award-number":["2017Z008"]}]},{"name":"Suzhou Health and Family Planning Commission","award":["LCZX201728"],"award-info":[{"award-number":["LCZX201728"]}]},{"name":"international joint project in National Natural Science Foundation of China","award":["81720108026"],"award-info":[{"award-number":["81720108026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Aspergillus<\/jats:italic> species are emerging causative agents of non-dermatophyte mold onychomycosis. In this study, 48 <jats:italic>Aspergillus<\/jats:italic> isolates were obtained from patients with onychomycosis in Mashhad, Iran, during 2015\u20132018. The aim is to identify the <jats:italic>Aspergillus<\/jats:italic> isolates to the species level by using partial calmodulin and beta-tubulin gene sequencing and MALDI-TOF MS, and to evaluate their in vitro susceptibility to ten antifungal drugs: terbinafine, itraconazole, voriconazole, posaconazole, ravuconazole, isavuconazole, caspofungin, micafungin, anidulafungin and amphotericin B according to CLSI M38-A3. Our results indicate that <jats:italic>A.flavus<\/jats:italic> (n\u2009=\u200938, 79%) is the most common <jats:italic>Aspergillus<\/jats:italic> species causing onychomycosis in Mashhad, Iran. Other detected species were <jats:italic>A. terreus<\/jats:italic> (n\u2009=\u20093), <jats:italic>A. tubingensis<\/jats:italic> (n\u2009=\u20092), <jats:italic>A. niger<\/jats:italic> (n\u2009=\u20091), <jats:italic>A. welwitschiae<\/jats:italic> (n\u2009=\u20091), <jats:italic>A. minisclerotigenes<\/jats:italic> (n\u2009=\u20091), <jats:italic>A. citrinoterreus<\/jats:italic> (n\u2009=\u20091) and <jats:italic>A. ochraceus<\/jats:italic> (n\u2009=\u20091). <jats:italic>Aspergillus flavus<\/jats:italic>, <jats:italic>A. terreus<\/jats:italic> and <jats:italic>A. niger<\/jats:italic> isolates were correctly identified at the species level by MALDI-TOF MS, while all cryptic species were misidentified. In conclusion, <jats:italic>A. flavus<\/jats:italic> is the predominant <jats:italic>Aspergillus<\/jats:italic> species causing onychomycosis due to <jats:italic>Aspergillus<\/jats:italic> spp. in Mashhad, Iran. MALDI-TOF MS holds promise as a fast and accurate identification tool, particularly for common <jats:italic>Aspergillus<\/jats:italic> species. It is important that the current database of reference spectra, representing different <jats:italic>Aspergillus<\/jats:italic> species is expanded to increase the precision of the species-level identification. Terbinafine, posaconazole and echinocandins were i<jats:italic>n vitro<\/jats:italic> most active against the studies <jats:italic>Aspergillus<\/jats:italic> isolates <jats:italic>and<\/jats:italic> terbinafine could be the first choice for treatment of onychomycosis due to <jats:italic>Aspergillus<\/jats:italic>.<\/jats:p>","DOI":"10.1038\/s41598-021-86038-z","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T11:04:07Z","timestamp":1616583847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran"],"prefix":"10.1038","volume":"11","author":[{"given":"Xue","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos","family":"Houbraken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongfen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Javad","family":"Najafzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"86038_CR1","doi-asserted-by":"publisher","first-page":"e40543","DOI":"10.5812\/jjm.40543","volume":"9","author":"M Motamedi","year":"2016","unstructured":"Motamedi, M. et al. Growing incidence of non-dermatophyte onychomycosis in Tehran, Iran.  Jundishapur J. Microbiol. 9, e40543. https:\/\/doi.org\/10.5812\/jjm.40543 (2016).","journal-title":"Jundishapur J. Microbiol."},{"key":"86038_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mycmed.2014.12.001","volume":"25","author":"S Nouripour-Sisakht","year":"2015","unstructured":"Nouripour-Sisakht, S. et al. Aspergillus species as emerging causative agents of onychomycosis. J. mycol. Med. 25, 101\u2013107. https:\/\/doi.org\/10.1016\/j.mycmed.2014.12.001 (2015).","journal-title":"J. mycol. Med."},{"key":"86038_CR3","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/exd.12807","volume":"24","author":"M Zotti","year":"2015","unstructured":"Zotti, M., Agnoletti, A. F., Vizzini, A., Cozzani, E. & Parodi, A. Onychomycosis from Aspergillus melleus, a novel pathogen for humans. Fungal identification and in vitro drug susceptibility. Exp. Dermatol. 24, 966\u2013968. https:\/\/doi.org\/10.1111\/exd.12807 (2015).","journal-title":"Exp. Dermatol."},{"key":"86038_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11046-017-0222-9","volume":"183","author":"F Bongomin","year":"2018","unstructured":"Bongomin, F., Batac, C. R., Richardson, M. D. & Denning, D. W. A Review of onychomycosis due to aspergillus species. Mycopathologia 183, 485\u2013493. https:\/\/doi.org\/10.1007\/s11046-017-0222-9 (2018).","journal-title":"Mycopathologia"},{"key":"86038_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1439-0507.2008.01679.x","volume":"53","author":"M Chadeganipour","year":"2010","unstructured":"Chadeganipour, M., Nilipour, S. & Ahmadi, G. Study of onychomycosis in Isfahan, Iran. Mycoses 53, 153\u2013157. https:\/\/doi.org\/10.1111\/j.1439-0507.2008.01679.x (2010).","journal-title":"Mycoses"},{"key":"86038_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1439-0507.2009.01703.x","volume":"53","author":"SJ Hashemi","year":"2010","unstructured":"Hashemi, S. J. et al. Onychomycosis in Tehran: mycological study of 504 patients. Mycoses 53, 251\u2013255. https:\/\/doi.org\/10.1111\/j.1439-0507.2009.01703.x (2010).","journal-title":"Mycoses"},{"key":"86038_CR7","first-page":"320","volume":"42","author":"A Mikaeili","year":"2013","unstructured":"Mikaeili, A. & Karimi, I. The incidence of onychomycosis infection among patients referred to hospitals in Kermanshah province, Western Iran. Iran. J. Public Health 42, 320\u2013325 (2013).","journal-title":"Iran. J. Public Health"},{"key":"86038_CR8","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.amjmed.2011.10.008","volume":"125","author":"L Ostrosky-Zeichner","year":"2012","unstructured":"Ostrosky-Zeichner, L. Invasive mycoses: diagnostic challenges. Am. J. Med. 125, S14-24. https:\/\/doi.org\/10.1016\/j.amjmed.2011.10.008 (2012).","journal-title":"Am. J. Med."},{"key":"86038_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.simyco.2014.07.004","volume":"78","author":"RA Samson","year":"2014","unstructured":"Samson, R. A. et al. Phylogeny, identification and nomenclature of the genus of Aspergillus. Stud. Mycol. 78, 141\u2013173. https:\/\/doi.org\/10.1016\/j.simyco.2014.07.004 (2014).","journal-title":"Stud. Mycol."},{"key":"86038_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11046-014-9757-1","volume":"178","author":"M Sanguinetti","year":"2014","unstructured":"Sanguinetti, M. & Posteraro, B. MALDI-TOF mass spectrometry: any use for Aspergilli?. Mycopathologia 178, 417\u2013426. https:\/\/doi.org\/10.1007\/s11046-014-9757-1 (2014).","journal-title":"Mycopathologia"},{"key":"86038_CR11","doi-asserted-by":"publisher","unstructured":"Sanguinetti, M. & Posteraro, B. Identification of Molds by Matrix-Assisted Laser Desorption Ionization-Time ofipaon, M., Torres-Sanchez, M. J. & Aznar, J. Identification of clinical isolates of Aspergillus, including cryptic species, by matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Med. Mycol. 56, 838\u2013846, https:\/\/doi.org\/10.1093\/mmy\/myx115 (2018).","DOI":"10.1093\/mmy\/myx115"},{"key":"86038_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1128\/jcm.01640-16","volume":"55","author":"JPZ Siqueira","year":"2017","unstructured":"Siqueira, J. P. Z. et al. Species of asp flight mass spectrometry. J. Clin. Microbiol. 55, 369\u2013379. https:\/\/doi.org\/10.1128\/jcm.01640-16 (2017).","journal-title":"J. Clin. Microbiol."},{"key":"86038_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/mmy\/myx085","volume":"56","author":"MR Vidal-Acuna","year":"2018","unstructured":"Vidal-Acuna, M. R. Ruiz-Perez de Pergillus section Aspergillus from clinical samples in the United States. Med. Mycol. 56, 541\u2013550. https:\/\/doi.org\/10.1093\/mmy\/myx085 (2018).","journal-title":"Med. Mycol."},{"key":"86038_CR14","doi-asserted-by":"publisher","unstructured":"J.Houbraken. et al. Classification of Aspergillus, Penicillium, Talaromyces and related genera (Eurotiales): an overview of families, genera, subgenera, sections, series and species. Stud. Mycol. 95, 5\u2013169, https:\/\/doi.org\/10.1016\/j.simyco.2020.05.002 (2020).","DOI":"10.1016\/j.simyco.2020.05.002"},{"key":"86038_CR15","doi-asserted-by":"publisher","first-page":"e28425","DOI":"10.1371\/journal.pone.0028425","volume":"6","author":"C Cassagne","year":"2011","unstructured":"Cassagne, C. et al. Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. PLoS ONE 6, e28425. https:\/\/doi.org\/10.1371\/journal.pone.0028425 (2011).","journal-title":"PLoS ONE"},{"key":"86038_CR16","unstructured":"Wayne, P. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 3rd ed. Approved standard. CLSI document M38-A3. Clinical and Laboratory Standards Institute (2017)."},{"key":"86038_CR17","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/jdv.12323","volume":"28","author":"B Sigurgeirsson","year":"2014","unstructured":"Sigurgeirsson, B. & Baran, R. The prevalence of onychomycosis in the global population: a literature study. JEADV 28, 1480\u20131491. https:\/\/doi.org\/10.1111\/jdv.12323 (2014).","journal-title":"JEADV"},{"key":"86038_CR18","first-page":"98","volume":"6","author":"P Afshar","year":"2014","unstructured":"Afshar, P., Khodavaisy, S., Kalhori, S., Ghasemi, M. & Razavyoon, T. Onychomycosis in north-East of iran. Iran. J. Microbiol. 6, 98\u2013103 (2014).","journal-title":"Iran. J. Microbiol."},{"key":"86038_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D33D61G259","volume":"18","author":"RR Ranawaka","year":"2012","unstructured":"Ranawaka, R. R., de Silva, N. & Ragunathan, R. W. Non-dermatophyte mold onychomycosis in Sri Lanka. Dermatol. Online J. 18, 7 (2012).","journal-title":"Dermatol. Online J."},{"key":"86038_CR20","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/j.1365-4632.2012.05509.x","volume":"51","author":"S Nkondjo Minkoumou","year":"2012","unstructured":"Nkondjo Minkoumou, S., Fabrizi, V. & Papini, M. Onychomycosis in Cameroon: a clinical and epidemiological study among dermatological patients. Int. J. Dermatol. 51, 1474\u20131477. https:\/\/doi.org\/10.1111\/j.1365-4632.2012.05509.x (2012).","journal-title":"Int. J. Dermatol."},{"key":"86038_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/0377-4929.48915","volume":"52","author":"L Adhikari","year":"2009","unstructured":"Adhikari, L., Das Gupta, A., Pal, R. & Singh, T. S. Clinico-etiologic correlates of onychomycosis in Sikkim. Indian J. Pathol. Microbiol. 52, 194\u2013197. https:\/\/doi.org\/10.4103\/0377-4929.48915 (2009).","journal-title":"Indian J. Pathol. Microbiol."},{"key":"86038_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/0019-5154.41651","volume":"53","author":"NK Das","year":"2008","unstructured":"Das, N. K. et al. A study on the etiological agent and clinico-mycological correlation of fingernail onychomycosis in eastern India. Indian J. Dermatol. 53, 75\u201379. https:\/\/doi.org\/10.4103\/0019-5154.41651 (2008).","journal-title":"Indian J. Dermatol."},{"key":"86038_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11046-005-6872-z","volume":"160","author":"S Hilmioglu-Polat","year":"2005","unstructured":"Hilmioglu-Polat, S. et al. Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkey: a prospective study. Mycopathologia 160, 125\u2013128. https:\/\/doi.org\/10.1007\/s11046-005-6872-z (2005).","journal-title":"Mycopathologia"},{"key":"86038_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000079593","volume":"209","author":"C Gianni","year":"2004","unstructured":"Gianni, C. & Romano, C. Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine. Dermatology 209, 104\u2013110. https:\/\/doi.org\/10.1159\/000079593 (2004).","journal-title":"Dermatology"},{"key":"86038_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2133.1974.tb06718.x","volume":"91","author":"MP English","year":"1974","unstructured":"English, M. P. & Atkinson, R. Onychomycosis in elderly chiropody patients. Br. J. Dermatol. 91, 67\u201372. https:\/\/doi.org\/10.1111\/j.1365-2133.1974.tb06718.x (1974).","journal-title":"Br. J. Dermatol."},{"key":"86038_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1439-0507.2005.01161.x","volume":"48","author":"C Romano","year":"2005","unstructured":"Romano, C., Papini, M., Ghilardi, A. & Gianni, C. Onychomycosis in children: a survey of 46 cases. Mycoses 48, 430\u2013437. https:\/\/doi.org\/10.1111\/j.1439-0507.2005.01161.x (2005).","journal-title":"Mycoses"},{"key":"86038_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.diagmicrobio.2015.10.027","volume":"84","author":"CC Tsang","year":"2016","unstructured":"Tsang, C. C. et al. Genetic diversity of Aspergillus species isolated from onychomycosis and Aspergillus hongkongensis sp nov, with implications to antifungal susceptibility testing. Diagn. Microbiol. Inf. Dis. 84, 125\u2013134. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.10.027 (2016).","journal-title":"Diagn. Microbiol. Inf. Dis."},{"key":"86038_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1439-0507.2011.02103.x","volume":"55","author":"G Szigeti","year":"2012","unstructured":"Szigeti, G. et al. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses 55, 333\u2013338. https:\/\/doi.org\/10.1111\/j.1439-0507.2011.02103.x (2012).","journal-title":"Mycoses"},{"key":"86038_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11046-012-9529-8","volume":"174","author":"G Szigeti","year":"2012","unstructured":"Szigeti, G. et al. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary. Mycopathologia 174, 143\u2013147. https:\/\/doi.org\/10.1007\/s11046-012-9529-8 (2012).","journal-title":"Mycopathologia"},{"key":"86038_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11046-018-0299-9","volume":"184","author":"S Hagiwara","year":"2019","unstructured":"Hagiwara, S. et al. The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan. Mycopathologia 184, 13\u201321. https:\/\/doi.org\/10.1007\/s11046-018-0299-9 (2019).","journal-title":"Mycopathologia"},{"key":"86038_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1099\/ijs.0.65123-0","volume":"58","author":"MB Pildain","year":"2008","unstructured":"Pildain, M. B. et al. Two novel aflatoxin-producing Aspergillus species from Argentinean peanuts. Int. J. Syst. Evol. Microbiol. 58, 725\u2013735. https:\/\/doi.org\/10.1099\/ijs.0.65123-0 (2008).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"86038_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/1471-2334-14-358","volume":"14","author":"P Dehghan","year":"2014","unstructured":"Dehghan, P. et al. Multilocus variable-number tandem-repeat analysis of clinical isolates of Aspergillus flavus from Iran reveals the first cases of Aspergillus minisclerotigenes associated with human infection. BMC Infect. Dis. 14, 358. https:\/\/doi.org\/10.1186\/1471-2334-14-358 (2014).","journal-title":"BMC Infect. Dis."},{"key":"86038_CR33","doi-asserted-by":"publisher","unstructured":"Karimizadeh Esfahani, M., Eslampoor, A., Dolatabadi, S., Najafzadeh, M. J. & Houbraken, J. First case of fungal keratitis due to Aspergillus minisclerotigenes in Iran. Current Med. Mycol. 5, 45\u201348,https:\/\/doi.org\/10.18502\/cmm.5.2.1162 (2019).","DOI":"10.18502\/cmm.5.2.1162"},{"key":"86038_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1128\/JCM.03088-14","volume":"53","author":"J Guinea","year":"2015","unstructured":"Guinea, J. et al. Aspergillus citrinoterreus, a new species of section Terrei isolated from samples of patients with nonhematological predisposing conditions. J. Clin. Microbiol. 53, 611\u2013617. https:\/\/doi.org\/10.1128\/JCM.03088-14 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"86038_CR35","doi-asserted-by":"publisher","unstructured":"Imbert, S. et al. Species identification and in vitro antifungal susceptibility of Aspergillus terreus species complex clinical isolates from a french multicenter study. Antimicrobial Agents Chemother. 62, doi:https:\/\/doi.org\/10.1128\/AAC.02315-17 (2018).","DOI":"10.1128\/AAC.02315-17"},{"key":"86038_CR36","doi-asserted-by":"publisher","unstructured":"Risslegger, B. et al. A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 23, 776 e771\u2013776 e775, https:\/\/doi.org\/10.1016\/j.cmi.2017.04.012 (2017).","DOI":"10.1016\/j.cmi.2017.04.012"},{"key":"86038_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fmicb.2018.00516","volume":"9","author":"T Zoran","year":"2018","unstructured":"Zoran, T. et al. Azole-resistance in Aspergillus terreus and related species: An emerging problem or a rare phenomenon?. Front. Microbiol. 9, 516. https:\/\/doi.org\/10.3389\/fmicb.2018.00516 (2018).","journal-title":"Front. Microbiol."},{"key":"86038_CR38","first-page":"254","volume":"65","author":"M Wierzbicka","year":"1997","unstructured":"Wierzbicka, M., Podsiadlo, B. & Janczarski, M. Invasive pulmonary aspergillosis caused by Aspergillus ochraceus. Pneumonol. Alergol. Pol. 65, 254\u2013260 (1997).","journal-title":"Pneumonol. Alergol. Pol."},{"key":"86038_CR39","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/ajcp\/70.5.840","volume":"70","author":"HS Novey","year":"1978","unstructured":"Novey, H. S. & Wells, I. D. Allergic bronchopulmonary aspergillosis caused by Aspergillus ochraceus. Am. J. Clin. Pathol. 70, 840\u2013843. https:\/\/doi.org\/10.1093\/ajcp\/70.5.840 (1978).","journal-title":"Am. J. Clin. Pathol."},{"key":"86038_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1469-0691.2011.03599.x","volume":"18","author":"E De Carolis","year":"2012","unstructured":"De Carolis, E. et al. Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Microbiol. Inf. 18, 475\u2013484. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03599.x (2012).","journal-title":"Clin. Microbiol. Inf."},{"key":"86038_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.simyco.2018.06.001","volume":"93","author":"JC Frisvad","year":"2019","unstructured":"Frisvad, J. C. et al. Taxonomy of Aspergillus section Flavi and their production of aflatoxins, ochratoxins and other mycotoxins. Stud. Mycol. 93, 1\u201363. https:\/\/doi.org\/10.1016\/j.simyco.2018.06.001 (2019).","journal-title":"Stud. Mycol."},{"key":"86038_CR42","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/myc.13010","volume":"62","author":"MT Hedayati","year":"2019","unstructured":"Hedayati, M. T. et al. Discrimination of Aspergillus flavus from Aspergillus oryzae by matrix-assisted laser desorption\/ionisation time-of-flight (MALDI-TOF) mass spectrometry. Mycoses 62, 1182\u20131188. https:\/\/doi.org\/10.1111\/myc.13010 (2019).","journal-title":"Mycoses"},{"key":"86038_CR43","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1128\/jcm.00962-16","volume":"54","author":"A Masih","year":"2016","unstructured":"Masih, A. et al. Identification by molecular methods and matrix-assisted laser desorption ionization-time of flight mass spectrometry and antifungal susceptibility profiles of clinically significant rare Aspergillus species in a referral chest Hospital in Delhi, India.  J. Clin. Microbiol. 54, 2354\u20132364. https:\/\/doi.org\/10.1128\/jcm.00962-16 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"86038_CR44","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1128\/aac.32.5.780","volume":"32","author":"HJ Schmitt","year":"1988","unstructured":"Schmitt, H. J. et al. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp. Antimicrob. Agents Chemother. 32, 780\u2013781. https:\/\/doi.org\/10.1128\/aac.32.5.780 (1988).","journal-title":"Antimicrob. Agents Chemother."},{"key":"86038_CR45","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1128\/AAC.45.6.1882-1885.2001","volume":"45","author":"CB Moore","year":"2001","unstructured":"Moore, C. B., Walls, C. M. & Denning, D. W. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B. Antimicrob. Agents Chemother. 45, 1882\u20131885. https:\/\/doi.org\/10.1128\/AAC.45.6.1882-1885.2001 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"86038_CR46","unstructured":"Wayne, P. Reformance standards for antifungal susceptibility testing of filamentous fungi, 1 st ed. CLSI document M61. Clinical and Laboratory Standards Institute (2017)."},{"key":"86038_CR47","doi-asserted-by":"publisher","unstructured":"Pfaller, M. A., Messer, S. A., Hollis, R. J. & Jones, R. N. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrobial Agents Chemother. 46, 1032\u20131037, https:\/\/doi.org\/10.1128\/aac.46.4.1032-1037.2002 (2002).","DOI":"10.1128\/aac.46.4.1032-1037.2002"},{"key":"86038_CR48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ijantimicag.2012.01.013","volume":"39","author":"C Colozza","year":"2012","unstructured":"Colozza, C. et al. In vitro activities of amphotericin B and Am Bisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies. Int. J. Antimicrob. Agents 39, 440\u2013443. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.01.013 (2012).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"86038_CR49","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1128\/AAC.01902-12","volume":"57","author":"SS Goncalves","year":"2013","unstructured":"Goncalves, S. S., Stchigel, A. M., Cano, J., Guarro, J. & Colombo, A. L. In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi. Antimicrob. Agents Chemother. 57, 1944\u20131947. https:\/\/doi.org\/10.1128\/AAC.01902-12 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"86038_CR50","doi-asserted-by":"publisher","unstructured":"Taghizadeh-Armaki, M. et al. Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates. Antimicrobial Agents Chemother. 61, https:\/\/doi.org\/10.1128\/AAC.00004-17 (2017).","DOI":"10.1128\/AAC.00004-17"},{"key":"86038_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1471-2334-13-126","volume":"13","author":"F Al-Wathiqi","year":"2013","unstructured":"Al-Wathiqi, F., Ahmad, S. & Khan, Z. Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait. BMC Infect. Dis. 13, 126. https:\/\/doi.org\/10.1186\/1471-2334-13-126 (2013).","journal-title":"BMC Infect. Dis."},{"key":"86038_CR52","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1128\/JCM.03233-14","volume":"53","author":"Y Li","year":"2015","unstructured":"Li, Y., Wan, Z., Liu, W. & Li, R. Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins. J. Clin. Microbiol. 53, 702\u2013705. https:\/\/doi.org\/10.1128\/JCM.03233-14 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"86038_CR53","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2141.2005.05763.x","volume":"131","author":"C Lass-Florl","year":"2005","unstructured":"Lass-Florl, C. et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br. J. Haematol. 131, 201\u2013207. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05763.x (2005).","journal-title":"Br. J. Haematol."},{"key":"86038_CR54","doi-asserted-by":"publisher","unstructured":"Espinel-Ingroff, A. et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrobial Agents Chemother. 55, 5150\u20135154, https:\/\/doi.org\/10.1128\/AAC.00686-11 (2011).","DOI":"10.1128\/AAC.00686-11"},{"key":"86038_CR55","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2141.2005.05763.x","volume":"131","author":"C Lass-Fl\u00f6rl","year":"2005","unstructured":"Lass-Fl\u00f6rl, C. et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br. J. Haematol. 131, 201\u2013207. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05763.x (2005).","journal-title":"Br. J. Haematol."},{"key":"86038_CR56","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1128\/jcm.41.12.5525-5529.2003","volume":"41","author":"JW Baddley","year":"2003","unstructured":"Baddley, J. W., Pappas, P. G., Smith, A. C. & Moser, S. A. Epidemiology of Aspergillus terreus at a university hospital. J. Clin. Microbiol. 41, 5525\u20135529. https:\/\/doi.org\/10.1128\/jcm.41.12.5525-5529.2003 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"86038_CR57","doi-asserted-by":"publisher","unstructured":"Pfaller, M. A. et al. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method. J Clin. Microbiol. 47, 3323\u20133325, https:\/\/doi.org\/10.1128\/JCM.01155-09 (2009).","DOI":"10.1128\/JCM.01155-09"},{"key":"86038_CR58","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1128\/AAC.00335-08","volume":"53","author":"C Lass-Florl","year":"2009","unstructured":"Lass-Florl, C., Alastruey-Izquierdo, A., Cuenca-Estrella, M., Perkhofer, S. & Rodriguez-Tudela, J. L. In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing. Antimicrob. Agents Chemother. 53, 794\u2013795. https:\/\/doi.org\/10.1128\/AAC.00335-08 (2009).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86038-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:49:28Z","timestamp":1670046568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86038-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["86038"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-86038-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,24]]},"assertion":[{"value":"6 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6808"}}